Surgery in stage III non-small-cell lung cancer

被引：7
|
作者：
Eberhardt, Wilfried E. E. [1 ]
Stamatis, Georgios [2 ]
Stuschke, Martin [3 ]
机构：
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Canc Res, W German Tumour Ctr, D-45122 Essen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Thorac Endoscopy & Thorac Surg, Ruhrlandklin, D-45122 Essen, Germany
[3] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiat Oncol, W German Tumour Ctr, D-45122 Essen, Germany
来源：
LANCET | 2009年 / 374卷 / 9687期
关键词：
PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; TRIAL; CHEMORADIATION; SURVIVAL;
D O I：
10.1016/S0140-6736(09)61026-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 360
页数：2
相关论文
共 50 条
  • [1] The role of surgery in stage III non-small-cell lung cancer
    Baggstrom, Maria Q.
    Govindan, Ramaswamy
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (05): : 557 - 559
  • [2] The role of surgery in the treatment of stage III non-small-cell lung cancer
    Gallo A.M.
    Donington J.S.
    [J]. Current Oncology Reports, 2007, 9 (4) : 247 - 254
  • [3] Surgery for Elderly Patients with Stage III Non-Small-Cell Lung Cancer (NSCLC)?
    Passlick, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S91 - S92
  • [4] Durvalumab in Stage III Non-Small-Cell Lung Cancer
    Santoni, Matteo
    Battelli, Nicola
    Buti, Sebastiano
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09): : 869 - 869
  • [5] Mortality related to neoadjuvant therapy and surgery for stage III non-small-cell lung cancer
    Clamon, Gerald H.
    Parekh, Kalpaj R.
    [J]. CLINICAL LUNG CANCER, 2008, 9 (04) : 213 - 216
  • [6] Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer
    Bonnette, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (02) : 105 - 114
  • [7] Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer
    Rizvi, Naiyer A.
    Peters, Solange
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1986 - 1988
  • [8] Gefitinib maintenance in stage III non-small-cell lung cancer
    Stewart, David J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4849 - 4850
  • [9] Multimodality therapy for stage III non-small-cell lung cancer
    Farray, D
    Mirkovic, N
    Albain, KS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3257 - 3269
  • [10] Prognostic factors in stage III non-small-cell lung cancer
    Ademuyiwa, Foluso O.
    Johnson, Cynthia S.
    White, Angela S.
    Breen, Timothy E.
    Harvey, Jayme
    Neubauer, Marcus
    Hanna, Nasser H.
    [J]. CLINICAL LUNG CANCER, 2007, 8 (08) : 478 - 482
12345